 |
|
|
|
September 2000 Cover
|
|
Researchers from PathoGenesis in Seattle have developed a potential treatment for drug-resistant tuberculosis (TB). The scientists report that a family of drugs called nitroimidazopyrans has proven effective against TB
in animal tests. Given sufficient funding and successful clinical tests, the drug could receive regulatory clearance in five to eight years, the researchers said, which would make it the first new anti-TB therapy in three decades.
Editor's Note: from Nature
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
